NO983244L - 5H-Tiazolo [3,2-a] pyrimidinderivater - Google Patents

5H-Tiazolo [3,2-a] pyrimidinderivater

Info

Publication number: NO983244L
Authority: NO; Norway
Prior art keywords: thiazolo; pyrimidine derivatives; pyrimidine; derivatives
Prior art date: 1997-07-18

Application number

NO983244A

Other languages

English (en)

Other versions

NO310512B1 (no

NO983244D0 (no

Inventor

Geo Adam

Sabine Kolczewski

Vincent Mutel

J Rgen Wichmann

Thomas Johannes Woltering

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-18

Filing date

1998-07-14

Publication date

1999-01-19

1998-07-14 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1998-07-14 Publication of NO983244D0 publication Critical patent/NO983244D0/no

1999-01-19 Publication of NO983244L publication Critical patent/NO983244L/no

2001-07-16 Publication of NO310512B1 publication Critical patent/NO310512B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
- C07D239/40—One sulfur atom as doubly bound sulfur atom or as unsubstituted mercapto radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Addiction (AREA)
Anesthesiology (AREA)
Ophthalmology & Optometry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO19983244A 1997-07-18 1998-07-14 5H-Tiazolo [3,2-a] pyrimidinderivater NO310512B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP97112324		1997-07-18

Publications (3)

Publication Number	Publication Date
NO983244D0 NO983244D0 (no)	1998-07-14
NO983244L true NO983244L (no)	1999-01-19
NO310512B1 NO310512B1 (no)	2001-07-16

Family

ID=8227080

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19983244A NO310512B1 (no)	1997-07-18	1998-07-14	5H-Tiazolo [3,2-a] pyrimidinderivater

Country Status (32)

Country	Link
US (1)	US5958931A (no)
EP (1)	EP0891978B1 (no)
JP (1)	JP3100573B2 (no)
KR (1)	KR100296837B1 (no)
CN (1)	CN1102596C (no)
AR (1)	AR016129A1 (no)
AT (1)	ATE214704T1 (no)
AU (1)	AU738207B2 (no)
BR (1)	BR9802482A (no)
CA (1)	CA2243234C (no)
CO (1)	CO5210884A1 (no)
CZ (1)	CZ288944B6 (no)
DE (1)	DE69804273T2 (no)
DK (1)	DK0891978T3 (no)
ES (1)	ES2172840T3 (no)
HR (1)	HRP980398B1 (no)
HU (1)	HUP9801587A3 (no)
ID (1)	ID21824A (no)
IL (1)	IL125358A (no)
MA (1)	MA26520A1 (no)
NO (1)	NO310512B1 (no)
NZ (1)	NZ330988A (no)
PE (1)	PE97499A1 (no)
PL (1)	PL190218B1 (no)
PT (1)	PT891978E (no)
RU (1)	RU2197493C2 (no)
SI (1)	SI0891978T1 (no)
TR (1)	TR199801367A2 (no)
TW (1)	TW523518B (no)
UY (1)	UY25095A1 (no)
YU (1)	YU29798A (no)
ZA (1)	ZA986250B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1074549B1 (en) *	1999-08-06	2003-11-19	F. Hoffmann-La Roche Ag	Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors
HUP0401858A3 (en) *	2001-01-31	2009-06-29	Lundbeck & Co As H	Gal3 receptor antagonist pyrimidine and indolone-derivatives and their use for preparation of pharmaceutical compositions suitable for the treatment of depression and/or anxiety
JPWO2002102807A1 (ja) *	2001-06-14	2004-09-30	萬有製薬株式会社	新規イソキサゾロピリドン誘導体及びその用途
US7329662B2 (en) *	2003-10-03	2008-02-12	Hoffmann-La Roche Inc.	Pyrazolo-pyridine
KR100847160B1 (ko) *	2004-06-21	2008-07-17	에프. 호프만-라 로슈 아게	피라졸로 피리미딘 유도체
EP1761541B1 (en) *	2004-06-21	2008-01-09	F.Hoffmann-La Roche Ag	Pyrrazolo-pyrimidine derivatives
BRPI0607927A2 (pt)	2005-02-11	2009-10-20	Hoffmann La Roche	derivados de pirazol-pirimidina
KR100973609B1 (ko)	2005-03-23	2010-08-03	에프. 호프만-라 로슈 아게	ｍＧｌｕＲ2 길항제로서 아세틸렌일-피라졸로-피리미딘유도체
AR053347A1 (es) *	2005-04-06	2007-05-02	Astrazeneca Ab	Derivados de [1,3]tiazolo[4,5-d]pirimidin-2(3h)-ona 5,7-sustituidos
UA90707C2 (en) *	2005-04-06	2010-05-25	Астразенека Аб	Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
CN101273040B (zh)	2005-09-27	2011-11-09	弗·哈夫曼-拉罗切有限公司	作为mglur2拮抗剂的*二唑基吡唑并嘧啶类化合物
AR059898A1 (es) *	2006-03-15	2008-05-07	Janssen Pharmaceutica Nv	Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) *	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
AU2008297877C1 (en) *	2007-09-14	2013-11-07	Addex Pharma S.A.	1,3-disubstituted-4-phenyl-1 H-pyridin-2-ones
KR20100065191A (ko)	2007-09-14	2010-06-15	오르토-맥닐-얀센 파마슈티칼스 인코포레이티드	１,３-이치환된 ４-(아릴-ｘ-페닐)-１ｈ-피리딘-２-온
DE602008004794D1 (de) *	2007-09-14	2011-03-10	Addex Pharmaceuticals Sa	1',3'-disubstituierte 4-phenyl-3,4,5,6-tetrahydro-2h,1'h-ä1,4'übipyridinyl-2'-one
US8785486B2 (en) *	2007-11-14	2014-07-22	Janssen Pharmaceuticals, Inc.	Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
EP2344470B1 (en)	2008-09-02	2013-11-06	Janssen Pharmaceuticals, Inc.	3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
CN102186477B (zh)	2008-10-16	2013-07-17	奥梅-杨森制药有限公司	作为代谢型谷氨酸受体调节剂的吲哚和苯并吗啉衍生物
CN102232074B (zh)	2008-11-28	2014-12-03	奥梅-杨森制药有限公司	作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
CN101503414B (zh) *	2009-03-04	2013-10-30	沈阳药科大学	噻唑并[3,2-b]-1,2,4-三嗪衍生物及其应用
AR076861A1 (es)	2009-05-12	2011-07-13	Addex Pharma Sa	Derivados de 1,2,4-triazolo (4,3-a)piridina y su uso como moduladores alostericos positivos de los receptores de mglur2
WO2010130422A1 (en)	2009-05-12	2010-11-18	Ortho-Mcneil-Janssen Pharmaceuticals, Inc	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ES2552455T3 (es)	2010-11-08	2015-11-30	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
US8993591B2 (en)	2010-11-08	2015-03-31	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
CA2814998C (en)	2010-11-08	2019-10-29	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
RU2703273C2 (ru)	2013-10-11	2019-10-16	Ф. Хоффманн-Ля Рош Аг	Тиазолопиримидиноны в качестве модуляторов активности рецепторов nmda
PH12019500127B1 (en)	2014-01-21	2022-05-04	Janssen Pharmaceutica Nv	Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
SMT201900545T1 (it)	2014-01-21	2019-11-13	Janssen Pharmaceutica Nv	Combinazioni comprendenti modulatori allosterici positivi o agonisti ortosterici del recettore glutammatergico metabotropico sottotipo 2 e loro utilizzo
CN110461854A (zh) *	2017-03-31	2019-11-15	巴斯夫欧洲公司	制备手性2,3-二氢噻唑并[3,2-a]嘧啶-4-鎓化合物的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3660418A (en) *	1970-03-16	1972-05-02	Sandoz Ag	Certain 2 3 5 6-tetrahydroimidazo(2 1-b)thiazoles
GB1582744A (en) *	1976-06-04	1981-01-14	Gruenenthal Gmbh	7h-thiazolo (and 1,3,4-thiadiazolo-)(3,2-a) pyrimidin-7-one-5-carboxylic acids derivatives and medicaments therof
SU1169330A1 (ru) *	1983-11-10	1995-11-27	Институт Тонкой Органической Химии Им.А.Л.Мнджояна	Способ получения 4-п-алкоксифенил-2,6-диоксогексагидропиримидинов
HUT42077A (en) *	1985-06-03	1987-06-29	Squibb & Sons Inc	Process for producing diesters of 2-tioxo- or 2-oxo-pyrimidine-1,5-dicarboxylic acid and 1-acyl-pyrimidine-5-carboxylic acids and esters
DD296492A5 (de) *	1989-06-13	1991-12-05	��@��@�K@��k��	Pyrrolo-[2,1-b]-thiazol-derivate und verfahren zu deren herstellung
EP0524055A1 (fr) *	1991-07-19	1993-01-20	Synthelabo	Dérivés d'imidazo[2,1-b]benzothiazole-3-acétamide, leur préparation et leur application en thérapeutique
ZA931109B (en) *	1992-03-04	1993-09-22	Akzo Nv	Tetrahydropyrimidine derivatives.
PL182285B1 (pl) *	1994-08-12	2001-12-31	Lilly Co Eli	Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL
GB9609976D0 (en) *	1996-05-13	1996-07-17	Lilly Industries Ltd	Pharmaceutical compounds
AU3783497A (en) *	1996-08-09	1998-03-06	Yamanouchi Pharmaceutical Co., Ltd.	Metabotropic glutamate receptor agonists

1998
- 1998-07-11 DE DE69804273T patent/DE69804273T2/de not_active Expired - Fee Related
- 1998-07-11 PT PT98112915T patent/PT891978E/pt unknown
- 1998-07-11 EP EP98112915A patent/EP0891978B1/en not_active Expired - Lifetime
- 1998-07-11 AT AT98112915T patent/ATE214704T1/de not_active IP Right Cessation
- 1998-07-11 ES ES98112915T patent/ES2172840T3/es not_active Expired - Lifetime
- 1998-07-11 SI SI9830130T patent/SI0891978T1/xx unknown
- 1998-07-11 DK DK98112915T patent/DK0891978T3/da active
- 1998-07-14 NO NO19983244A patent/NO310512B1/no not_active IP Right Cessation
- 1998-07-14 MA MA25167A patent/MA26520A1/fr unknown
- 1998-07-14 ID IDP981000A patent/ID21824A/id unknown
- 1998-07-14 US US09/115,191 patent/US5958931A/en not_active Expired - Fee Related
- 1998-07-14 NZ NZ330988A patent/NZ330988A/xx unknown
- 1998-07-14 ZA ZA986250A patent/ZA986250B/xx unknown
- 1998-07-14 TR TR1998/01367A patent/TR199801367A2/xx unknown
- 1998-07-15 HU HU9801587A patent/HUP9801587A3/hu unknown
- 1998-07-15 IL IL12535898A patent/IL125358A/en not_active IP Right Cessation
- 1998-07-15 PE PE1998000625A patent/PE97499A1/es not_active Application Discontinuation
- 1998-07-15 CN CN98116063A patent/CN1102596C/zh not_active Expired - Fee Related
- 1998-07-15 YU YU29798A patent/YU29798A/sh unknown
- 1998-07-15 CA CA002243234A patent/CA2243234C/en not_active Expired - Fee Related
- 1998-07-15 JP JP10199363A patent/JP3100573B2/ja not_active Expired - Fee Related
- 1998-07-16 CZ CZ19982239A patent/CZ288944B6/cs not_active IP Right Cessation
- 1998-07-16 UY UY25095A patent/UY25095A1/es unknown
- 1998-07-16 BR BR9802482-5A patent/BR9802482A/pt not_active Application Discontinuation
- 1998-07-16 CO CO98040510A patent/CO5210884A1/es not_active Application Discontinuation
- 1998-07-16 AR ARP980103469A patent/AR016129A1/es not_active Application Discontinuation
- 1998-07-16 KR KR1019980028788A patent/KR100296837B1/ko not_active Expired - Fee Related
- 1998-07-16 PL PL98327532A patent/PL190218B1/pl unknown
- 1998-07-16 HR HR980398A patent/HRP980398B1/xx not_active IP Right Cessation
- 1998-07-17 RU RU98114683/04A patent/RU2197493C2/ru not_active IP Right Cessation
- 1998-07-17 AU AU77302/98A patent/AU738207B2/en not_active Ceased
- 1998-07-21 TW TW087111834A patent/TW523518B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL125358A0 (en)	1999-03-12
YU29798A (sh)	2001-12-26
HU9801587D0 (en)	1998-09-28
PT891978E (pt)	2002-07-31
CA2243234A1 (en)	1999-01-18
CZ223998A3 (cs)	1999-02-17
CN1102596C (zh)	2003-03-05
EP0891978A3 (en)	1999-02-03
HK1018439A1 (en)	1999-12-24
CZ288944B6 (cs)	2001-10-17
ZA986250B (en)	1999-01-22
US5958931A (en)	1999-09-28
HUP9801587A2 (hu)	1999-11-29
MA26520A1 (fr)	2004-12-20
NO310512B1 (no)	2001-07-16
BR9802482A (pt)	2000-03-14
PL327532A1 (en)	1999-02-01
JPH1171380A (ja)	1999-03-16
ES2172840T3 (es)	2002-10-01
AU738207B2 (en)	2001-09-13
TR199801367A3 (tr)	1999-02-22
ID21824A (id)	1999-07-29
NZ330988A (en)	1999-03-29
KR100296837B1 (ko)	2001-10-26
DE69804273T2 (de)	2002-10-31
IL125358A (en)	2002-09-12
NO983244D0 (no)	1998-07-14
HRP980398B1 (en)	2002-06-30
CO5210884A1 (es)	2002-10-30
TW523518B (en)	2003-03-11
PL190218B1 (pl)	2005-11-30
ATE214704T1 (de)	2002-04-15
HRP980398A2 (en)	1999-04-30
DE69804273D1 (de)	2002-04-25
CA2243234C (en)	2007-09-18
SI0891978T1 (en)	2002-06-30
PE97499A1 (es)	1999-10-12
HUP9801587A3 (en)	2001-09-28
AU7730298A (en)	1999-01-28
KR19990013919A (ko)	1999-02-25
DK0891978T3 (da)	2002-07-01
RU2197493C2 (ru)	2003-01-27
UY25095A1 (es)	2001-01-31
EP0891978B1 (en)	2002-03-20
TR199801367A2 (xx)	1999-02-22
CN1206010A (zh)	1999-01-27
AR016129A1 (es)	2001-06-20
EP0891978A2 (en)	1999-01-20
JP3100573B2 (ja)	2000-10-16

Publication	Publication Date	Title
DE69804273D1 (de)	2002-04-25	5h-Thiazolo[3,2-a]pyrimidinderivate
DE60016615D1 (de)	2005-01-13	Pyrazolo[4,3-d]pyrimidinderivate
IS5721A (is)	2000-11-21	Pýróló [2,3-dl]pírimídín efnasambönd
DE69915675D1 (de)	2004-04-22	Triazolo[4,5-d]pyrimidin-derivate
ID26698A (id)	2001-02-01	SENYAWA-SENYAWA PIROLO [2,3-d] PIRIMIDINA
MA26851A1 (fr)	2004-12-20	Derives de pyrrolo [2,3-d] pyrimidine
ATE256123T1 (de)	2003-12-15	Pyrimidonderivate
PT1005446E (pt)	2004-06-30	Derivados de n-aroilfenilalanina
PT1003719E (pt)	2002-10-31	Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
BR9507666A (pt)	1997-09-23	Novos derivados de pirimidina
PT1027362E (pt)	2005-08-31	Derivados de cetolidos 2-halogeno-6-o-substituidos
DE69716901D1 (de)	2002-12-12	2,4-diaminopyrimidin-derivate
DE50001191D1 (de)	2003-03-06	Pyrazolo[4, 3-d]pyrimidine
FI972795L (fi)	1997-06-27	Pyrimidiinijohdannaisia
NO995033D0 (no)	1999-10-15	6,7-disubstituerte-4-aminopyrido[2,3-D]pyrimidinforbindelser
NO995035D0 (no)	1999-10-15	5,6,7-trisubstituerte-4-aminopyrido[2,3-D]pyrimidinforbindelser
PT1010699E (pt)	2005-08-31	Derivados de 3-oxadiazolil-1,6-naftiridina-2(h)-ona substituido em 5
EP0904271A4 (en)	2002-01-23	5,6,7,8-tetrahydro-pyrido [2,3-d] pyrimidines
EP0954316A4 (en)	2002-02-13	PYRIMIDINE DERIVATIVES

Legal Events

Date	Code	Title	Description
2005-05-02	MM1K	Lapsed by not paying the annual fees